Tabolacci, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 3.509
AS - Asia 2.490
EU - Europa 2.309
SA - Sud America 476
AF - Africa 61
OC - Oceania 8
Totale 8.853
Nazione #
US - Stati Uniti d'America 3.383
SG - Singapore 1.018
CN - Cina 578
IT - Italia 472
SE - Svezia 385
BR - Brasile 376
DE - Germania 373
VN - Vietnam 313
PL - Polonia 260
FR - Francia 187
GB - Regno Unito 130
UA - Ucraina 116
HK - Hong Kong 100
FI - Finlandia 92
IN - India 91
IE - Irlanda 89
JP - Giappone 72
CA - Canada 70
ID - Indonesia 61
BD - Bangladesh 51
NL - Olanda 47
RU - Federazione Russa 44
TR - Turchia 40
MX - Messico 36
AR - Argentina 34
IQ - Iraq 30
AT - Austria 23
KR - Corea 23
PK - Pakistan 23
ES - Italia 19
CL - Cile 18
VE - Venezuela 14
ZA - Sudafrica 14
AE - Emirati Arabi Uniti 13
BE - Belgio 13
CZ - Repubblica Ceca 13
CH - Svizzera 12
IR - Iran 12
EC - Ecuador 10
LT - Lituania 10
CO - Colombia 9
EG - Egitto 9
MA - Marocco 8
MY - Malesia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AU - Australia 7
CI - Costa d'Avorio 7
PH - Filippine 7
AZ - Azerbaigian 6
PY - Paraguay 6
JM - Giamaica 5
TT - Trinidad e Tobago 5
GA - Gabon 4
IL - Israele 4
KE - Kenya 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
AO - Angola 3
CR - Costa Rica 3
LB - Libano 3
LY - Libia 3
PE - Perù 3
TH - Thailandia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
GY - Guiana 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 8.849
Città #
Singapore 582
Ashburn 449
San Jose 323
Chandler 282
Warsaw 244
New York 147
Los Angeles 129
Rome 111
Ho Chi Minh City 109
Beijing 107
Hong Kong 88
Dublin 87
Hanoi 83
The Dalles 80
Milan 76
Wilmington 74
Hefei 73
Jacksonville 70
Nanjing 67
Seattle 67
Fairfield 65
Tokyo 63
Woodbridge 63
Ann Arbor 61
Buffalo 61
Lauterbourg 55
Council Bluffs 54
San Mateo 53
Jakarta 51
Santa Clara 50
Chicago 49
São Paulo 48
Cattolica 47
Houston 46
Helsinki 44
Munich 42
Dallas 41
Frankfurt am Main 39
Boston 32
Marseille 29
Cambridge 28
Nanchang 27
Kent 26
Moscow 24
London 22
North Bergen 22
Nuremberg 22
St Louis 22
Denver 19
Seoul 19
Boardman 18
Lawrence 18
Orem 18
Atlanta 17
Brooklyn 17
Da Nang 17
Izmir 17
Montreal 17
Rio de Janeiro 17
Toronto 17
Redwood City 15
Tianjin 15
Verona 15
Baghdad 14
Brasília 14
Philadelphia 14
Phoenix 14
Poplar 14
Salvador 14
Turku 14
Brussels 13
Chennai 13
Dearborn 13
Mexico City 13
Paris 13
Princeton 13
Bremen 12
Guangzhou 12
Hangzhou 12
Kunming 12
Washington 12
Amsterdam 11
Ankara 11
Brno 11
Charlotte 11
Lancaster 11
Mumbai 11
Nürnberg 11
San Francisco 11
Santiago 11
Shanghai 11
Bologna 10
Falls Church 10
Lappeenranta 10
Manchester 10
Pune 9
Stockholm 9
Zhengzhou 9
Bexley 8
Busto Arsizio 8
Totale 5.119
Nome #
Transcriptional reactivation of the FMR1 Gene. A possible approach to the treatment of the fragile X syndrome 393
CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations 342
Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments 296
Effects of remifentanil on human C20 microglial pro-inflammatory activation 283
Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene 253
DNA Methylation in the Diagnosis of Monogenic Diseases. 209
A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys 202
Role of CTCF protein in regulating FMR1 locus transcription. 202
Infantile Liver Failure Syndrome 1 associated with a novel variant of the LARS1 gene: Clinical, genetic, and functional characterization 201
A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy 193
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 191
Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells 187
L-acetylcarnitine treatment on fragile X patients hyperactive behaviour 186
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 185
Co-occurrence of fragile x syndrome with a second genetic condition: Three independent cases of double diagnosis 184
Mother and Daughter Carrying of the Same Pathogenic Variant in FGFR2 with Discordant Phenotype 178
Defining the role of the CGGBP1 protein in FMR1 gene expression 177
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 169
Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation 169
Treatment with Valproic acid ameiorates ADHD symptoms in Fragile X syndrome boys. 167
Assisted reproductive technology and congenital overgrowth:some speculations on a case of Pallister-Killian syndrome 159
Syndromic and Non-Syndromic Primary Failure of Tooth Eruption: A Genetic Overview 158
Simpson–Golabi–Behmel syndrome in a female: A case report and an unsolved issue 158
Mechanisms of the FMR1 Repeat Instability: How Does the CGG Sequence Expand? 150
Insertion of 16 amino acids in the BAR domain of the oligophrenin 1 protein causes mental retardation and cerebellar hypoplasia in an Italian family 150
Rutin Protects Fibroblasts from UVA Radiation through Stimulation of Nrf2 Pathway. 149
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception 143
DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome 143
The polyphenolic compound punicalagin protects skin fibroblasts from UVA radiation oxidative damage 142
Modest reactivation of the mutatnt FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation. 141
New Insight into the genotype-phenotype correlation of PTH1R variants and primary failure of tooth eruption on an Italian Cohort 139
No Correlation between X Chromosome Inactivation Pattern and Autistic Spectrum Disorders in an Italian Cohort of Patients 133
Epigenetic modifications of the FMR1 gene 132
Mitochondrial Dysfunction Causes Cell Death in Patients Affected by Fragile-X-Associated Disorders 131
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 130
Epigenetics, fragile X syndrome and transcriptional therapy. 129
Reversion to Normal of FMR1 Expanded Alleles: A Rare Event in Two Independent Fragile X Syndrome Families 129
The FRAXopathies: Definition, overview, and update 128
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 127
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro. 127
Genetic Aspects of Tooth Agenesis 125
Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals 121
Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1gene in fragile X cells treated with 5-aza-deoxycitidine 119
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. 118
Permanent First Molar Eruption Failure in Children: clinical management of three clinical scenarios 109
RADX Gene Variant May Predispose to Familial Asperger Syndrome 109
Permanent first molar eruption failure in children: leading signs for early diagnosis 104
The role of sevoflurane exposure on systemic inflammation and neuroinflammation: a systematic review and meta-analysis of in vivo and in vitro studies 100
Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. 100
Evidence for a Functional Link Between the Nrf2 Signalling Pathway and Cytoprotective Effect of S-Petasin in Human Retinal Pigment Epithelium Cells Exposed to Oxidative Stress 93
Enviromental maternal exposures and the risk of premature birth and intrauterine growth restriction: The Generation Gemelli study protocol of newborn exposome 90
X-linked mental retardation (XLMR): from clinical conditions to cloned genes 81
A truncating mutation in the IL1RAPL1 gene is responsible for X-linked mental retardation in the MRX21 family 70
Telomeric associations and chromosome instability in ataxia telangiectasia T cells characterized by TCL1 expression 64
Two brothers with 22q13 deletion syndrome and features suggestive of the Clark-Baraitser syndrome 61
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability 56
Molecular dissection of the events leading to inactivation of the FMR1 gene 54
MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty-nine novel mutations identified 54
GAPO syndrome: a comprehensive examination and review of 105 clinical cases 49
Genetic Determinants of Primary Failure of Eruption: A Comprehensive Review of PTH1R Variants 45
Role of Circulating X-Chromosome Inactivation and Xist as Biomarkers in Female Carriers of Fabry Disease 23
Subcellular photoprotection through precision nutraceuticals: Divergent actions of rutin and punicalagin on redox and mitochondrial homeostasis in human dermal fibroblasts 16
FMR1 RNA int er action with DNMT1 blocks DNA methylation at the FMR1 locus 13
NLRP12 as a regulator of inflammation: insights into the correlation with autoinflammatory disorders 8
Polydatin Prevents UVA-Induced Damage in Human Dermal Fibroblasts by Maintaining Mitochondrial Integrity 8
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity 6
A gap analysis integrating In vitro - Research in HDR interventional radiotherapy (Modern Brachytherapy): Challenges, limitations, and future directions 1
Totale 8.962
Categoria #
all - tutte 32.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022432 33 78 5 33 27 13 17 43 16 18 88 61
2022/2023885 145 128 51 115 69 65 57 64 106 27 37 21
2023/2024649 30 116 36 78 29 104 61 12 8 29 76 70
2024/20251.346 22 40 75 74 80 65 36 68 240 96 315 235
2025/20263.928 413 131 220 475 589 232 743 163 306 257 172 227
2026/2027227 227 0 0 0 0 0 0 0 0 0 0 0
Totale 8.962